315 related articles for article (PubMed ID: 24394604)
1. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience.
Lombardi G; Musco S; Celso M; Del Corso F; Del Popolo G
Spinal Cord; 2014 Mar; 52(3):241-5. PubMed ID: 24394604
[TBL] [Abstract][Full Text] [Related]
2. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention.
Lombardi G; Musco S; Celso M; Ierardi A; Nelli F; Del Corso F; Del Popolo G
Spinal Cord; 2013 Jul; 51(7):571-8. PubMed ID: 23628893
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of intravesical electrostimulation on incomplete spinal cord patients suffering from chronic neurogenic non-obstructive retention: a 15-year single centre retrospective study.
Lombardi G; Celso M; Mencarini M; Nelli F; Del Popolo G
Spinal Cord; 2013 Mar; 51(3):232-7. PubMed ID: 23147136
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
Peeters K; Sahai A; De Ridder D; Van Der Aa F
BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
[TBL] [Abstract][Full Text] [Related]
5. Clinical concomitant benefits on pelvic floor dysfunctions after sacral neuromodulation in patients with incomplete spinal cord injury.
Lombardi G; Nelli F; Mencarini M; Del Popolo G
Spinal Cord; 2011 May; 49(5):629-36. PubMed ID: 21283086
[TBL] [Abstract][Full Text] [Related]
6. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
[TBL] [Abstract][Full Text] [Related]
7. Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function.
Lombardi G; Mondaini N; Giubilei G; Macchiarella A; Lecconi F; Del Popolo G
J Sex Med; 2008 Sep; 5(9):2135-40. PubMed ID: 18637993
[TBL] [Abstract][Full Text] [Related]
8. [Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic].
Otto W; Nowrotek A; Burger M; Wieland WF; Rößler W; Denzinger S
Aktuelle Urol; 2012 May; 43(3):162-6. PubMed ID: 22639025
[TBL] [Abstract][Full Text] [Related]
9. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury.
Redshaw JD; Lenherr SM; Elliott SP; Stoffel JT; Rosenbluth JP; Presson AP; Myers JB;
BMC Urol; 2018 Aug; 18(1):72. PubMed ID: 30157824
[TBL] [Abstract][Full Text] [Related]
10. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.
Gajewski JB; Al-Zahrani AA
BJU Int; 2011 Apr; 107(8):1258-64. PubMed ID: 20883483
[TBL] [Abstract][Full Text] [Related]
11. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction.
Daniels DH; Powell CR; Braasch MR; Kreder KJ
Neurourol Urodyn; 2010 Apr; 29(4):578-81. PubMed ID: 19760757
[TBL] [Abstract][Full Text] [Related]
12. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
[TBL] [Abstract][Full Text] [Related]
13. Early sacral neuromodulation ameliorates urinary bladder function and structure in complete spinal cord injury minipigs.
Keller EE; Patras I; Hutu I; Roider K; Sievert KD; Aigner L; Janetschek G; Lusuardi L; Zimmermann R; Bauer S
Neurourol Urodyn; 2020 Feb; 39(2):586-593. PubMed ID: 31868966
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms.
Lombardi G; Del Popolo G
Spinal Cord; 2009 Jun; 47(6):486-91. PubMed ID: 19238164
[TBL] [Abstract][Full Text] [Related]
15. A functional magnetic resonance imaging study of the effect of sacral neuromodulation on brain responses in women with Fowler's syndrome.
Kavia R; Dasgupta R; Critchley H; Fowler C; Griffiths D
BJU Int; 2010 Feb; 105(3):366-72. PubMed ID: 19735259
[TBL] [Abstract][Full Text] [Related]
16. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention.
Shaker HS; Hassouna M
J Urol; 1998 May; 159(5):1476-8. PubMed ID: 9554336
[TBL] [Abstract][Full Text] [Related]
17. Sacral neuromodulation for nonobstructive urinary retention--is success predictable?
Goh M; Diokno AC
J Urol; 2007 Jul; 178(1):197-9; discussion 199. PubMed ID: 17499773
[TBL] [Abstract][Full Text] [Related]
18. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study.
van Kerrebroeck PE; van Voskuilen AC; Heesakkers JP; Lycklama á Nijholt AA; Siegel S; Jonas U; Fowler CJ; Fall M; Gajewski JB; Hassouna MM; Cappellano F; Elhilali MM; Milam DF; Das AK; Dijkema HE; van den Hombergh U
J Urol; 2007 Nov; 178(5):2029-34. PubMed ID: 17869298
[TBL] [Abstract][Full Text] [Related]
19. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
Parnell BA; Howard JF; Geller EJ
Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
[TBL] [Abstract][Full Text] [Related]
20. Prolonged percutaneous SNM testing does not cause infection-related explanation.
Amend B; Bedke J; Khalil M; Stenzl A; Sievert KD
BJU Int; 2013 Mar; 111(3):485-91. PubMed ID: 22738331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
